Log in or Sign up for Free to view tailored content for your specialty!
Thyroid News
Linsitinib for thyroid eye disease shows proptosis reduction, safety in phase 2b/3 trial
Linsitinib, an oral small molecule under development for the treatment of thyroid eye disease, demonstrated proptosis reduction and safety in the phase 2b/3 LIDS trial, according to a press release from Sling Therapeutics.
GLP-1 receptor agonists tied to similar thyroid cancer risk as DPP-IV inhibitors
Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according to findings published in Thyroid.
Hypothyroidism may be associated with increased medical, implant complications after TSA
According to results published in the Journal of Shoulder and Elbow Surgery, patients with hypothyroidism may be at an increased risk for medical and implant-related complications after total shoulder arthroplasty vs. controls.
Log in or Sign up for Free to view tailored content for your specialty!
Adults experience less fear, worry after surgery for low-risk papillary thyroid cancer
Adults with low-risk thyroid cancer who underwent surgery had significant reductions in cancer-related fear and worry after their procedure compared with before surgery, researchers reported.
Suicide rates rise among adolescents, young adults with cancer, often years after diagnosis
Suicide rates for individuals diagnosed with cancer increased over the past 2 decades, according to results of a retrospective study.
Radioactive iodine for thyroid cancer linked to risk for melanoma, other skin cancers
Patients with primary thyroid cancer who received radioactive iodine exhibited increased risk for melanoma and other nonkeratinocyte skin cancers, according to study results.
Company warns about risk for severe infections with drug approved for lung, thyroid cancers
Data from a phase 3 trial designed to compare pralsetinib with standard therapy for certain patients with advanced lung cancer revealed a risk for severe — and potentially fatal — infections with the drug, according to its manufacturer.
Parathyroid hormone therapy normalizes calcium for most with hypoparathyroidism
The majority of adults with hypoparathyroidism achieved normal serum calcium levels with palopegteriparatide at 1 year without supplemental vitamin D or calcium, according to data from a phase 3 open-label extension.
Adults with Graves’ disease treated with antithyroid drugs at higher risk for some cancers
Adults with Graves’ disease treated with antithyroid drugs have a higher risk for multiple types of cancer compared with the general population, according to findings published in Thyroid.
Timing of mild maternal hypothyroidism ‘pivotal’ for predicting pregnancy outcomes
Third-trimester subclinical hypothyroidism and first- and third-trimester isolated maternal hypothyroxinemia were tied to various adverse pregnancy outcomes, highlighting the importance of trimester-specific thyroid function evaluations.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read